Anat Cohen-Dayag

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Anat Cohen-Dayag
Nationality  Israel
Alma mater

Weizmann Institute of Science

Ben-Gurion University
Scientific career
Fields biochemist

Anat Cohen-Dayag is an Israeli businesswoman. She is president and chief executive officer of the Israeli Biotechnology firm Compugen Ltd, a company involved in drug discovery. She had worked as a scientist at the R&D department of Orgenics.

Education[edit]

She holds a B.Sc. in Biology from the Ben-Gurion University, and has obtained an MSc in Chemical Immunology and a PhD in Biological Chemistry from the Weizmann Institute of Science. [1] [2] [3]

References[edit]

  1. ^ "Anat Cohen Dayag - Forbes". People.forbes.com. 2012-04-18. Retrieved 2012-08-14. 
  2. ^ "Dr Anat Cohen-Dayag | antibody congress". Terrapinn.com. Retrieved 2012-08-14. 
  3. ^ "Compugen Appoints Dr. Anat Cohen-Dayag as President and CEO". FierceBiotech. Retrieved 2012-08-14.